Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|January 1, 2008
Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitorConstantine G Boojamra, Richard L Mackman, David Y Markevitch, et al.Bioorganic & Medicinal Chemistry Letters|December 18, 2007
Synthesis and anti-HIV activity of 2'-fluorine modified nucleoside phosphonates: analogs of GS-9148Richard L Mackman, Kuei-Ying Lin, Constantine G Boojamra, et al.Journal of Clinical Apheresis|May 22, 2026
Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients?Robert Weinstein, Zehra Stara Yuksel, Christina Anderson, et al.Bioorganic & Medicinal Chemistry|June 15, 2007
Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugsRichard L Mackman, Lijun Zhang, Vidya Prasad, et al.Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Synthesis and anti-HIV activity of cyclic pyrimidine phosphonomethoxy nucleosides and their prodrugs: a comparison of phosphonates and corresponding nucleosidesRichard L Mackman, Lijun Zhang, Vidya Prasad, et al.Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonatesRichard L Mackman, Constantine G Boojamra, Vidya Prasad, et al.Antimicrobial Agents and Chemotherapy|December 7, 2007
Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131Tomas Cihlar, Adrian S Ray, Constantine G Boojamra, et al.Bioorganic & Medicinal Chemistry|April 23, 2010
Discovery of GS-9131: Design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148Richard L Mackman, Adrian S Ray, Hon C Hui, et al.Pageof 1